Mettler-Toledo International (NYSE:MTD) Lowered to Hold Rating by StockNews.com

StockNews.com downgraded shares of Mettler-Toledo International (NYSE:MTD) from a buy rating to a hold rating in a research report released on Monday morning.

A number of other analysts have also issued reports on the company. Citigroup raised Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,400.00 target price on the stock in a report on Monday, April 7th. Wells Fargo & Company boosted their target price on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an “equal weight” rating in a research report on Monday. Robert W. Baird reduced their price target on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a “neutral” rating for the company in a report on Tuesday, April 22nd. Jefferies Financial Group upgraded shares of Mettler-Toledo International from an “underperform” rating to a “hold” rating and dropped their price objective for the stock from $1,200.00 to $1,110.00 in a report on Monday. Finally, Evercore ISI upped their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a research report on Monday, February 10th. Seven investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $1,296.13.

Mettler-Toledo International Stock Performance

NYSE MTD opened at $1,090.24 on Monday. Mettler-Toledo International has a 1 year low of $946.69 and a 1 year high of $1,546.93. The stock has a market capitalization of $22.72 billion, a P/E ratio of 26.90, a P/E/G ratio of 3.30 and a beta of 1.40. The business’s fifty day moving average is $1,132.87 and its two-hundred day moving average is $1,229.48.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share for the quarter, beating the consensus estimate of $7.90 by $0.29. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. The company had revenue of $883.74 million for the quarter, compared to analysts’ expectations of $876.61 million. During the same quarter in the previous year, the business posted $8.89 EPS. The business’s revenue for the quarter was down 4.6% on a year-over-year basis. On average, research analysts forecast that Mettler-Toledo International will post 42.71 earnings per share for the current year.

Insider Buying and Selling at Mettler-Toledo International

In other news, insider Christian Magloth sold 790 shares of the business’s stock in a transaction on Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the sale, the insider now owns 734 shares in the company, valued at approximately $964,248.46. The trade was a 51.84 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Gerry Keller sold 600 shares of the company’s stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the completion of the sale, the insider now directly owns 6 shares in the company, valued at approximately $8,108.04. The trade was a 99.01 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.94% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of the company. Farther Finance Advisors LLC increased its holdings in Mettler-Toledo International by 14.3% during the 4th quarter. Farther Finance Advisors LLC now owns 64 shares of the medical instruments supplier’s stock valued at $78,000 after purchasing an additional 8 shares in the last quarter. M3 Advisory Group LLC increased its stake in shares of Mettler-Toledo International by 5.8% in the fourth quarter. M3 Advisory Group LLC now owns 165 shares of the medical instruments supplier’s stock valued at $202,000 after buying an additional 9 shares in the last quarter. Apollon Wealth Management LLC increased its stake in shares of Mettler-Toledo International by 2.5% in the fourth quarter. Apollon Wealth Management LLC now owns 368 shares of the medical instruments supplier’s stock valued at $451,000 after buying an additional 9 shares in the last quarter. Steward Partners Investment Advisory LLC raised its holdings in shares of Mettler-Toledo International by 3.0% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 306 shares of the medical instruments supplier’s stock valued at $374,000 after buying an additional 9 shares during the last quarter. Finally, Atlantic Union Bankshares Corp lifted its position in Mettler-Toledo International by 0.5% during the 4th quarter. Atlantic Union Bankshares Corp now owns 2,083 shares of the medical instruments supplier’s stock worth $2,549,000 after buying an additional 10 shares in the last quarter. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.